Latest Asx Listing Rules News

Island Pharmaceuticals has raised $3.6 million through a strategic share placement to advance its lead antiviral drug ISLA-101’s clinical development and broaden its asset portfolio ahead of pivotal Phase 2a/b trial results.

Janus Electric Holdings Limited will have its trading suspension lifted and resume quotation on the ASX from 21 May 2025 after meeting key listing requirements.

Macarthur Minerals has secured $250,000 through unsecured convertible notes to bolster its working capital and support ongoing operations amid challenging market conditions.

Yowie Group Ltd has firmly rejected the validity of director removal and nomination notices purportedly from Keybridge Capital, while confirming its status as Keybridge’s largest creditor with over $6.6 million owed. The company also detailed a recent share placement amid ongoing regulatory scrutiny.

Merino & Co has amended its quarterly report to correct expenditure figures and clarify related party payments, while reporting significant operational progress including new product launches and cryptocurrency integration.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.

Atomo Diagnostics Limited has announced a capital raising initiative comprising a Share Purchase Plan (SPP) and a Placement, aiming to raise up to $1 million through the SPP and additional funds via a Placement, subject to shareholder approval at a June 23 meeting.

Andromeda Metals has successfully raised $5 million through a share placement to institutional investors, aiming to accelerate development of its Great White and HPA projects. The company also plans to issue options that could inject further capital if exercised.

Dotz Nano Limited has announced a A$1.2 million private placement at a discounted share price, accompanied by options, to bolster working capital and support the commercialisation of its carbon capture technology.

A shareholder has lodged a formal application with the Takeovers Panel challenging FBR Limited’s recent share placements and governance practices, raising concerns over disclosure and shareholder engagement.

OFX Group Limited has requested a trading halt following significant price and volume spikes in its securities, ahead of its scheduled full year results announcement for FY25.

Alvo Minerals has voluntarily suspended trading of its shares on the ASX as it finalizes an Entitlement Offer and prepares to announce progress on the Lavra Velha Project acquisition.